Antibiotic Resistance Market

Global Market Study on Antibiotic Resistance: Approval & Launch of Novel Therapeutics Aiding Market Expansion

Antibiotic Resistance Market Segmented By Pathogen such as Staphylococcus aureus, Streptococcus pneumonia, Neisseria gonorrhoeae, Enterococcus faecium, Escherichia coli, Klebsiella pneumonia, Shigella, Clostridium difficile with Mechanism of Action such as Cell Wall, Protein, DNA, RNA Synthesis Inhibitors

  • February-2021
  • PMRREP27895
  • 272 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion & Exclusion/ Scope of the Report

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Development Trends

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion & Exclusion/ Scope of the Report

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Development Trends

    3.3. Key Regulations

4. Key Success Factors

    4.1. Disease Epidemiology

    4.2. Key Regulation Scenario

    4.3. Pipeline Analysis

    4.4. Treatment Regime (Prescription Pattern)

    4.5. Reimbursement Scenario

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Per Capita Healthcare Expenditure Outlook

        5.1.3. Regional Healthcare Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Top Companies Historical Growth

        5.2.2. Product Availability

        5.2.3. Product Adoption

        5.2.4. Procedure Cost

        5.2.5. Increasing Case of Toxicology and New Product Launches

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

    5.4. Value Chain Analysis 

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Drug Class 

        6.4.2. Revenue By Pathogen

        6.4.3. Revenue By Disease

        6.4.4. Revenue By Mechanism of action

        6.4.5. Revenue By Distribution Channel

        6.4.6. Revenue By Region

    6.5. 2020 Market Scenario

    6.6. Quarter by Quarter Forecast

    6.7. Projected recovery Quarter

7. Global Antibiotic Resistance Market Volume (Mn Units) Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Volume (Mn- Units) Analysis, 2016-2020

    7.2. Current and Future Market Volume (Mn- Units) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Antibiotic Resistance Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Device Type

    8.2. Global Average Pricing Analysis Benchmark

9. Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Opportunity Analysis, 2021-2031

10. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Drug Class 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Mn Units) By Drug Class, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Drug Class, 2021-2031

        10.3.1. Beta Lactam Antibiotic

        10.3.2. Cephalosporin

        10.3.3. Quinolones Antibiotic

        10.3.4. Macrolide Antibiotic

        10.3.5. Tetracycline

        10.3.6. Oxazolidinones

        10.3.7. Others

    10.4. Market Attractiveness Analysis By Drug Class 

11. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Pathogen 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Pathogen, 2016-2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Pathogen, 2021-2031

        11.3.1. Staphylococcus aureus

        11.3.2. Streptococcus pneumonia

        11.3.3. Neisseria gonorrhoeae

        11.3.4. Enterococcus faecium

        11.3.5. Escherichia coli

        11.3.6. Klebsiella Pneumonia

        11.3.7. Shigella

        11.3.8. Clostridium difficile

        11.3.9. Others

    11.4. Market Attractiveness Analysis By Pathogen 

12. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Disease

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Disease, 2016-2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease, 2021-2031

        12.3.1. Community Acquired Bacterial Pneumonia (CABP)

        12.3.2. Hospitals Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)

        12.3.3. Complicated Urinary Tract Infections (CUTI)

        12.3.4. Complicated Intra-Abdominal Infections (CIAI)

        12.3.5. Blood Stream Infections (BSI)

        12.3.6. Abdominal Infection and Diarrhoea (Clostridium difficile infections (CDI) & Shigella)

        12.3.7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

        12.3.8. Drug Resistant Gonorrhoeae

    12.4. Market Attractiveness Analysis By Disease

13. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Mechanism of Action

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis By Mechanism of Action, 2016-2020

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mechanism of Action, 2021-2031

        13.3.1. Cell Wall Synthesis Inhibitors

        13.3.2. Protein Synthesis Inhibitors

        13.3.3. DNA Synthesis Inhibitors

        13.3.4. RNA Synthesis Inhibitors

        13.3.5. Others

    13.4. Market Attractiveness Analysis By Disease

14. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016-2020

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2021-2031

        14.3.1. Hospitals Pharmacies

        14.3.2. Retail Pharmacies

        14.3.3. Online Pharmacies

    14.4. Market Attractiveness Analysis By Distribution Channel

15. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Region

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Analysis By Region, 2016-2020

    15.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        15.3.1. North America

        15.3.2. Latin America

        15.3.3. East Asia

        15.3.4. South Asia

        15.3.5. Oceania

        15.3.6. Middle East & Africa

    15.4. Market Attractiveness Analysis By Region

16. North America Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020

    16.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        16.3.1. By Country

            16.3.1.1. U.S.

            16.3.1.2. Canada

        16.3.2. By Drug Class

        16.3.3. By Pathogen

        16.3.4. By Disease

        16.3.5. By Mechanism of action

        16.3.6. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Latin America Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020

    17.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        17.3.1.  By Country

            17.3.1.1. Brazil

            17.3.1.2. Mexico

            17.3.1.3. Argentina

            17.3.1.4. Rest of Latin America

        17.3.2. By Drug Class

        17.3.3. By Pathogen

        17.3.4. By Disease

        17.3.5. By Mechanism of action

        17.3.6. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Europe Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020

    18.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        18.3.1. By Country

            18.3.1.1. Germany

            18.3.1.2. Italy

            18.3.1.3. France

            18.3.1.4. U.K.

            18.3.1.5. Spain

            18.3.1.6. BENELUX

            18.3.1.7. Russia

            18.3.1.8. Rest of Europe

        18.3.2. By Drug Class

        18.3.3. By Pathogen

        18.3.4. By Disease

        18.3.5. By Mechanism of action

        18.3.6. By Distribution Channel

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. East Asia Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020

    19.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        19.3.1. By Country

            19.3.1.1. China

            19.3.1.2. Japan

            19.3.1.3. South Korea

        19.3.2. By Drug Class

        19.3.3. By Pathogen

        19.3.4. By Disease

        19.3.5. By Mechanism of action

        19.3.6. By Distribution Channel

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. South Asia Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Analysis By Market Taxonomy, 2016-2020

    20.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        20.3.1. By Country

            20.3.1.1. India

            20.3.1.2. Thailand

            20.3.1.3. Indonesia

            20.3.1.4. Malaysia

            20.3.1.5. Rest of South Asia

        20.3.2. By Drug Class

        20.3.3. By Pathogen

        20.3.4. By Disease

        20.3.5. By Mechanism of action

        20.3.6. By Distribution Channel

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Oceania Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    21.1. Introduction

    21.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Analysis By Market Taxonomy, 2016-2020

    21.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        21.3.1. By Country

            21.3.1.1. Australia

            21.3.1.2. New Zealand

        21.3.2. By Drug Class

        21.3.3. By Pathogen

        21.3.4. By Disease

        21.3.5. By Mechanism of action

        21.3.6. By Distribution Channel

    21.4. Market Attractiveness Analysis

    21.5. Key Market Participants - Intensity Mapping

    21.6. Drivers and Restraints - Impact Analysis

22. Middle East and Africa Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    22.1. Introduction

    22.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020

    22.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units)  Analysis and Forecast By Region, 2021-2031

        22.3.1. By Country

            22.3.1.1. GCC Countries

            22.3.1.2. Turkey

            22.3.1.3. South Africa

            22.3.1.4. Rest of Middle East and Africa

        22.3.2. By Drug Class

        22.3.3. By Pathogen

        22.3.4. By Disease

        22.3.5. By Mechanism of action

        22.3.6. By Distribution Channel

    22.4. Market Attractiveness Analysis

    22.5. Key Market Participants - Intensity Mapping

    22.6. Drivers and Restraints - Impact Analysis

23. Key and Emerging Countries Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    23.1. Introduction

        23.1.1. Market Value Proportion Analysis, By Key Countries

        23.1.2. Global Vs. Country Growth Comparison

    23.2. U.S. Antibiotic Resistance Market Analysis

        23.2.1. By Drug Class

        23.2.2. By Pathogen

        23.2.3. By Disease

        23.2.4. By Mechanism of action

        23.2.5. By Distribution Channel

    23.3. Canada Antibiotic Resistance Market Analysis

        23.3.1. By Drug Class

        23.3.2. By Pathogen

        23.3.3. By Disease

        23.3.4. By Mechanism of action

        23.3.5. By Distribution Channel

    23.4. Mexico Antibiotic Resistance Market Analysis

        23.4.1. By Drug Class

        23.4.2. By Pathogen

        23.4.3. By Disease

        23.4.4. By Mechanism of action

        23.4.5. By Distribution Channel

    23.5. Brazil Antibiotic Resistance Market Analysis

        23.5.1. By Drug Class

        23.5.2. By Pathogen

        23.5.3. By Disease

        23.5.4. By Mechanism of action

        23.5.5. By Distribution Channel

    23.6. Argentina Antibiotic Resistance Market Analysis

        23.6.1. By Drug Class

        23.6.2. By Pathogen

        23.6.3. By Disease

        23.6.4. By Mechanism of action

        23.6.5. By Distribution Channel

    23.7. U.K. Antibiotic Resistance Market Analysis

        23.7.1. By Drug Class

        23.7.2. By Pathogen

        23.7.3. By Disease

        23.7.4. By Mechanism of action

        23.7.5. By Distribution Channel

    23.8. Germany Antibiotic Resistance Market Analysis

        23.8.1. By Drug Class

        23.8.2. By Pathogen

        23.8.3. By Disease

        23.8.4. By Mechanism of action

        23.8.5. By Distribution Channel

    23.9. France Antibiotic Resistance Market Analysis

        23.9.1. By Drug Class

        23.9.2. By Pathogen

        23.9.3. By Disease

        23.9.4. By Mechanism of action

        23.9.5. By Distribution Channel

    23.10. Italy Antibiotic Resistance Market Analysis

        23.10.1. By Drug Class

        23.10.2. By Pathogen

        23.10.3. By Disease

        23.10.4. By Mechanism of action

        23.10.5. By Distribution Channel

    23.11. Spain Antibiotic Resistance Market Analysis

        23.11.1. By Drug Class

        23.11.2. By Pathogen

        23.11.3. By Disease

        23.11.4. By Distribution Channel

    23.12. BENELUX Antibiotic Resistance Market Analysis

        23.12.1. By Drug Class

        23.12.2. By Pathogen

        23.12.3. By Disease

        23.12.4. By Mechanism of action

        23.12.5. By Distribution Channel

    23.13. Russia Antibiotic Resistance Market Analysis

        23.13.1. By Drug Class

        23.13.2. By Pathogen

        23.13.3. By Disease

        23.13.4. By Mechanism of action

        23.13.5. By Distribution Channel

    23.14. China Antibiotic Resistance Market Analysis

        23.14.1. By Drug Class

        23.14.2. By Pathogen

        23.14.3. By Disease

        23.14.4. By Mechanism of action

        23.14.5. By Distribution Channel

    23.15. Japan Antibiotic Resistance Market Analysis

        23.15.1. By Drug Class

        23.15.2. By Pathogen

        23.15.3. By Disease

        23.15.4. By Mechanism of action

        23.15.5. By Distribution Channel

    23.16. South Korea Antibiotic Resistance Market Analysis

        23.16.1. By Drug Class

        23.16.2. By Pathogen

        23.16.3. By Disease

        23.16.4. By Mechanism of action

        23.16.5. By Distribution Channel

    23.17. India Antibiotic Resistance Market Analysis

        23.17.1. By Drug Class

        23.17.2. By Pathogen

        23.17.3. By Disease

        23.17.4. By Mechanism of action

        23.17.5. By Distribution Channel

    23.18. Thailand Antibiotic Resistance Market Analysis

        23.18.1. By Drug Class

        23.18.2. By Pathogen

        23.18.3. By Disease

        23.18.4. By Mechanism of action

        23.18.5. By Distribution Channel

    23.19. Indonesia Antibiotic Resistance Market Analysis

        23.19.1. By Drug Class

        23.19.2. By Pathogen

        23.19.3. By Disease

        23.19.4. By Mechanism of action

        23.19.5. By Distribution Channel

    23.20. Malaysia Antibiotic Resistance Market Analysis

        23.20.1. By Drug Class

        23.20.2. By Pathogen

        23.20.3. By Disease

        23.20.4. By Mechanism of action

        23.20.5. By Distribution Channel

    23.21. Australia Antibiotic Resistance Market Analysis

        23.21.1. By Drug Class

        23.21.2. By Pathogen

        23.21.3. By Disease

        23.21.4. By Mechanism of action

        23.21.5. By Distribution Channel

    23.22. New Zealand Antibiotic Resistance Market Analysis

        23.22.1. By Drug Class

        23.22.2. By Pathogen

        23.22.3. By Disease

        23.22.4. By Mechanism of action

        23.22.5. By Distribution Channel

    23.23. GCC Countries Antibiotic Resistance Market Analysis

        23.23.1. By Drug Class

        23.23.2. By Pathogen

        23.23.3. By Disease

        23.23.4. By Mechanism of action

        23.23.5. By Distribution Channel

    23.24. Turkey Antibiotic Resistance Market Analysis

        23.24.1. By Drug Class

        23.24.2. By Pathogen

        23.24.3. By Disease

        23.24.4. By Mechanism of action

        23.24.5. By Distribution Channel

    23.25. North Aafrica Antibiotic Resistance Market Analysis

        23.25.1. By Drug Class

        23.25.2. By Pathogen

        23.25.3. By Disease

        23.25.4. By Mechanism of action

        23.25.5. By Distribution Channel

    23.26. South Africa Antibiotic Resistance Market Analysis

        23.26.1. By Drug Class

        23.26.2. By Pathogen

        23.26.3. By Disease

        23.26.4. By Mechanism of action

        23.26.5. By Distribution Channel

24. Market Structure Analysis

    24.1. Market Analysis by Tier of Companies 

    24.2. Market Share Analysis of Top Players

    24.3. Market Presence Analysis

        24.3.1. Regional footprint of Players

        24.3.2. Product Type foot print by Players

        24.3.3. Channel Foot Print by Players

25. Competition Analysis

    25.1. Competition Dashboard

    25.2. Pricing Analysis by Competition

    25.3. Competition Benchmarking

    25.4. Competition Deep Dive 

        25.4.1. Pfizer Inc

            25.4.1.1. Overview

            25.4.1.2. Product  Portfolio

            25.4.1.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.1.4. Sales Footprint

            25.4.1.5. Strategy Overview

                25.4.1.5.1. Marketing Strategy

                25.4.1.5.2. Product Strategy

                25.4.1.5.3. Channel Strategy

        25.4.2. GlaxoSmithKline plc 

            25.4.2.1. Overview

            25.4.2.2. Product  Portfolio

            25.4.2.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.2.4. Sales Footprint

            25.4.2.5. Strategy Overview

                25.4.2.5.1. Marketing Strategy

                25.4.2.5.2. Product Strategy

                25.4.2.5.3. Channel Strategy

        25.4.3. Merck & Co., Inc. 

            25.4.3.1. Overview

            25.4.3.2. Product  Portfolio

            25.4.3.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.3.4. Sales Footprint

            25.4.3.5. Strategy Overview

                25.4.3.5.1. Marketing Strategy

                25.4.3.5.2. Product Strategy

                25.4.3.5.3. Channel Strategy

        25.4.4. Johnsons & Johnson 

            25.4.4.1. Overview

            25.4.4.2. Product  Portfolio

            25.4.4.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.4.4. Sales Footprint

            25.4.4.5. Strategy Overview

                25.4.4.5.1. Marketing Strategy

                25.4.4.5.2. Product Strategy

                25.4.4.5.3. Channel Strategy

        25.4.5. Baxter Healthcare Corporation

            25.4.5.1. Overview

            25.4.5.2. Product  Portfolio

            25.4.5.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.5.4. Sales Footprint

            25.4.5.5. Strategy Overview

                25.4.5.5.1. Marketing Strategy

                25.4.5.5.2. Product Strategy

                25.4.5.5.3. Channel Strategy

        25.4.6. Zydus Cadila 

            25.4.6.1. Overview

            25.4.6.2. Product  Portfolio

            25.4.6.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.6.4. Sales Footprint

            25.4.6.5. Strategy Overview

                25.4.6.5.1. Marketing Strategy

                25.4.6.5.2. Product Strategy

                25.4.6.5.3. Channel Strategy

        25.4.7. Teva Pharmaceutical Industries Ltd. 

            25.4.7.1. Overview

            25.4.7.2. Product  Portfolio

            25.4.7.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.7.4. Sales Footprint

            25.4.7.5. Strategy Overview

                25.4.7.5.1. Marketing Strategy

                25.4.7.5.2. Product Strategy

                25.4.7.5.3. Channel Strategy

        25.4.8. Novartis AG 

            25.4.8.1. Overview

            25.4.8.2. Product  Portfolio

            25.4.8.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.8.4. Sales Footprint

            25.4.8.5. Strategy Overview

                25.4.8.5.1. Marketing Strategy

                25.4.8.5.2. Product Strategy

                25.4.8.5.3. Channel Strategy

        25.4.9. Dr. Reddy’s Laboratories Ltd.

            25.4.9.1. Overview

            25.4.9.2. Product  Portfolio

            25.4.9.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.9.4. Sales Footprint

            25.4.9.5. Strategy Overview

                25.4.9.5.1. Marketing Strategy

                25.4.9.5.2. Product Strategy

                25.4.9.5.3. Channel Strategy

        25.4.10. Mayne Pharma Group Limited. 

            25.4.10.1. Overview

            25.4.10.2. Product  Portfolio

            25.4.10.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.10.4. Sales Footprint

            25.4.10.5. Strategy Overview

                25.4.10.5.1. Marketing Strategy

                25.4.10.5.2. Product Strategy

                25.4.10.5.3. Channel Strategy

        25.4.11. Sun Pharmaceutical Industries Ltd. 

            25.4.11.1. Overview

            25.4.11.2. Product  Portfolio

            25.4.11.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.11.4. Sales Footprint

            25.4.11.5. Strategy Overview

                25.4.11.5.1. Marketing Strategy

                25.4.11.5.2. Product Strategy

                25.4.11.5.3. Channel Strategy

        25.4.12. Cipla Inc.

            25.4.12.1. Overview

            25.4.12.2. Product  Portfolio

            25.4.12.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.12.4. Sales Footprint

            25.4.12.5. Strategy Overview

                25.4.12.5.1. Marketing Strategy

                25.4.12.5.2. Product Strategy

                25.4.12.5.3. Channel Strategy

        25.4.13. Shanghai Pharmaceutical Group Co., Ltd. 

            25.4.13.1. Overview

            25.4.13.2. Product  Portfolio

            25.4.13.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.13.4. Sales Footprint

            25.4.13.5. Strategy Overview

                25.4.13.5.1. Marketing Strategy

                25.4.13.5.2. Product Strategy

                25.4.13.5.3. Channel Strategy

        25.4.14. Yuhan Corporation 

            25.4.14.1. Overview

            25.4.14.2. Product  Portfolio

            25.4.14.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.14.4. Sales Footprint

            25.4.14.5. Strategy Overview

                25.4.14.5.1. Marketing Strategy

                25.4.14.5.2. Product Strategy

                25.4.14.5.3. Channel Strategy

        25.4.15. Abbott Laboratories.

            25.4.15.1. Overview

            25.4.15.2. Product  Portfolio

            25.4.15.3. Profitability by Market Segments (Product/Channel/Region)

            25.4.15.4. Sales Footprint

            25.4.15.5. Strategy Overview

                25.4.15.5.1. Marketing Strategy

                25.4.15.5.2. Product Strategy

                25.4.15.5.3. Channel Strategy

26. Assumptions and Acronyms Used

27. Research Methodology

    3.3. Key Regulations

4. Key Success Factors

    4.1. Disease Epidemiology

    4.2. Key Regulation Scenario

    4.3. Pipeline Analysis

    4.4. Treatment Regime (Prescription Pattern)

    4.5. Reimbursement Scenario

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Per Capita Healthcare Expenditure Outlook

        5.1.3. Regional Healthcare Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Top Companies Historical Growth

        5.2.2. Product Availability

        5.2.3. Product Adoption

        5.2.4. Procedure Cost

        5.2.5. Increasing Case of Toxicology and New Product Launches

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

    5.4. Value Chain Analysis 

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Drug Class 

        6.4.2. Revenue By Pathogen

        6.4.3. Revenue By Disease

        6.4.4. Revenue By Mechanism of action

        6.4.5. Revenue By Distribution Channel

        6.4.6. Revenue By Region

    6.5. 2020 Market Scenario

    6.6. Quarter by Quarter Forecast

    6.7. Projected recovery Quarter

7. Global Antibiotic Resistance Market Volume (Mn Units) Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Volume (Mn- Units) Analysis, 2016-2020

    7.2. Current and Future Market Volume (Mn- Units) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Antibiotic Resistance Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Device Type

    8.2. Global Average Pricing Analysis Benchmark

9. Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Opportunity Analysis, 2021-2031

10. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Drug Class 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Mn Units) By Drug Class, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Drug Class, 2021-2031

        10.3.1. Beta Lactam Antibiotic

        10.3.2. Cephalosporin

        10.3.3. Quinolones Antibiotic

        10.3.4. Macrolide Antibiotic

        10.3.5. Tetracycline

        10.3.6. Oxazolidinones

        10.3.7. Others

    10.4. Market Attractiveness Analysis By Drug Class 

11. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Pathogen 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Pathogen, 2016-2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Pathogen, 2021-2031

        11.3.1. Staphylococcus aureus

        11.3.2. Streptococcus pneumonia

        11.3.3. Neisseria gonorrhoeae

        11.3.4. Enterococcus faecium

        11.3.5. Escherichia coli

        11.3.6. Klebsiella Pneumonia

        11.3.7. Shigella

        11.3.8. Clostridium difficile

        11.3.9. Others

    11.4. Market Attractiveness Analysis By Pathogen 

12. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Disease

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Disease, 2016-2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease, 2021-2031

        12.3.1. Community Acquired Bacterial Pneumonia (CABP)

        12.3.2. Hospitals Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)

        12.3.3. Complicated Urinary Tract Infections (CUTI)

        12.3.4. Complicated Intra-Abdominal Infections (CIAI)

        12.3.5. Blood Stream Infections (BSI)

        12.3.6. Abdominal Infection and Diarrhoea (Clostridium difficile infections (CDI) & Shigella)

        12.3.7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

        12.3.8. Drug Resistant Gonorrhoeae

    12.4. Market Attractiveness Analysis By Disease

13. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Mechanism of Action

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis By Mechanism of Action, 2016-2020

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mechanism of Action, 2021-2031

        13.3.1. Cell Wall Synthesis Inhibitors

        13.3.2. Protein Synthesis Inhibitors

        13.3.3. DNA Synthesis Inhibitors

        13.3.4. RNA Synthesis Inhibitors

        13.3.5. Others

    13.4. Market Attractiveness Analysis By Disease

14. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016-2020

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2021-2031

        14.3.1. Hospitals Pharmacies

        14.3.2. Retail Pharmacies

        14.3.3. Online Pharmacies

    14.4. Market Attractiveness Analysis By Distribution Channel

15. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Region

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Analysis By Region, 2016-2020

    15.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        15.3.1. North America

        15.3.2. Latin America

        15.3.3. East Asia

        15.3.4. South Asia

        15.3.5. Oceania

        15.3.6. Middle East & Africa

    15.4. Market Attractiveness Analysis By Region

16. North America Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020

    16.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        16.3.1. By Country

            16.3.1.1. U.S.

            16.3.1.2. Canada

        16.3.2. By Drug Class

        16.3.3. By Pathogen

        16.3.4. By Disease

        16.3.5. By Mechanism of action

        16.3.6. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Latin America Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020

    17.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        17.3.1.  By Country

            17.3.1.1. Brazil

            17.3.1.2. Mexico

            17.3.1.3. Argentina

            17.3.1.4. Rest of Latin America

        17.3.2. By Drug Class

        17.3.3. By Pathogen

        17.3.4. By Disease

        17.3.5. By Mechanism of action

        17.3.6. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Europe Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020

    18.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        18.3.1. By Country

            18.3.1.1. Germany

            18.3.1.2. Italy

            18.3.1.3. France

            18.3.1.4. U.K.

            18.3.1.5. Spain

            18.3.1.6. BENELUX

            18.3.1.7. Russia

            18.3.1.8. Rest of Europe

        18.3.2. By Drug Class

        18.3.3. By Pathogen

        18.3.4. By Disease

        18.3.5. By Mechanism of action

        18.3.6. By Distribution Channel

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. East Asia Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020

    19.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        19.3.1. By Country

            19.3.1.1. China

            19.3.1.2. Japan

            19.3.1.3. South Korea

        19.3.2. By Drug Class

        19.3.3. By Pathogen

        19.3.4. By Disease

        19.3.5. By Mechanism of action

        19.3.6. By Distribution Channel

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. South Asia Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Analysis By Market Taxonomy, 2016-2020

    20.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        20.3.1. By Country

            20.3.1.1. India

            20.3.1.2. Thailand

            20.3.1.3. Indonesia

            20.3.1.4. Malaysia

            20.3.1.5. Rest of South Asia

        20.3.2. By Drug Class

        20.3.3. By Pathogen

        20.3.4. By Disease

        20.3.5. By Mechanism of action

        20.3.6. By Distribution Channel

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Oceania Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    21.1. Introduction

    21.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Analysis By Market Taxonomy, 2016-2020

    21.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031

        21.3.1. By Country

            21.3.1.1. Australia

            21.3.1.2. New Zealand

        21.3.2. By Drug Class

        21.3.3. By Pathogen

        21.3.4. By Disease

        21.3.5. By Mechanism of action

        21.3.6. By Distribution Channel

    21.4. Market Attractiveness Analysis

    21.5. Key Market Participants - Intensity Mapping

    21.6. Drivers and Restraints - Impact Analysis

22. Middle East and Africa Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    22.1. Introduction

    22.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020

    22.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units)  Analysis and Forecast By Region, 2021-2031

        22.3.1. By Country

            22.3.1.1. GCC Countries

            22.3.1.2. Turkey

            22.3.1.3. South Africa

            22.3.1.4. Rest of Middle East and Africa

        22.3.2. By Drug Class

        22.3.3. By Pathogen

        22.3.4. By Disease

        22.3.5. By Mechanism of action

        22.3.6. By Distribution Channel

    22.4. Market Attractiveness Analysis

    22.5. Key Market Participants - Intensity Mapping

    22.6. Drivers and Restraints - Impact Analysis

23. Key and Emerging Countries Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031

    23.1. Introduction

        23.1.1. Market Value Proportion Analysis, By Key Countries

        23.1.2. Global Vs. Country Growth Comparison

    23.2. U.S. Antibiotic Resistance Market Analysis

        23.2.1. By Drug Class

        23.2.2. By Pathogen

        23.2.3. By Disease

        23.2.4. By Mechanism of action

        23.2.5. By Distribution Channel

    23.3. Canada Antibiotic Resistance Market Analysis

        23.3.1. By Drug Class

        23.3.2. By Pathogen

        23.3.3. By Disease

        23.3.4. By Mechanism of action

        23.3.5. By Distribution Channel

    23.4. Mexico Antibiotic Resistance Market Analysis

        23.4.1. By Drug Class

        23.4.2. By Pathogen

        23.4.3. By Disease

        23.4.4. By Mechanism of action

        23.4.5. By Distribution Channel

    23.5. Brazil Antibiotic Resistance Market Analysis

        23.5.1. By Drug Class

        23.5.2. By Pathogen

        23.5.3. By Disease

        23.5.4. By Mechanism of action

        23.5.5. By Distribution Channel

    23.6. Argentina Antibiotic Resistance Market Analysis

        23.6.1. By Drug Class

        23.6.2. By Pathogen

        23.6.3. By Disease

        23.6.4. By Mechanism of action

        23.6.5. By Distribution Channel

    23.7. U.K. Antibiotic Resistance Market Analysis

        23.7.1. By Drug Class

        23.7.2. By Pathogen

        23.7.3. By Disease

        23.7.4. By Mechanism of action

        23.7.5. By Distribution Channel

    23.8. Germany Antibiotic Resistance Market Analysis

        23.8.1. By Drug Class

        23.8.2. By Pathogen

        23.8.3. By Disease

        23.8.4. By Mechanism of action

        23.8.5. By Distribution Channel

    23.9. France Antibiotic Resistance Market Analysis

        23.9.1. By Drug Class

        23.9.2. By Pathogen

        23.9.3. By Disease

        23.9.4. By Mechanism of action

        23.9.5. By Distribution Channel

    23.10. Italy Antibiotic Resistance Market Analysis

        23.10.1. By Drug Class

        23.10.2. By Pathogen

        23.10.3. By Disease

        23.10.4. By Mechanism of action

        23.10.5. By Distribution Channel

    23.11. Spain Antibiotic Resistance Market Analysis

        23.11.1. By Drug Class

        23.11.2. By Pathogen

        23.11.3. By Disease

        23.11.4. By Distribution Channel

    23.12. BENELUX Antibiotic Resistance Market Analysis

        23.12.1. By Drug Class

        23.12.2. By Pathogen

        23.12.3. By Disease

        23.12.4. By Mechanism of action

        23.12.5. By Distribution Channel

    23.13. Russia Antibiotic Resistance Market Analysis

        23.13.1. By Drug Class

        23.13.2. By Pathogen

        23.13.3. By Disease

Find Out More about the Report Coverage

List of Tables

Table 01: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 01: Global Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 03: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease

Table 04: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 05: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 06: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel

Table 07: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Region

Table 08: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country

Table 09: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 10: North America Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 11: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease

Table 12: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 13: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 14: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel

Table 15: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country

Table 16: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 17: Latin America Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 18: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease

Table 19: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 20: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 21: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel

Table 22: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country

Table 23: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 24: Europe Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 25: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease

Table 26: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 27: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 28: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel

Table 29: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country

Table 30: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 31: South Asia Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 32: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease

Table 33: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 34: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 35: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel

Table 36: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country

Table 37: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 38: East Asia Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 39: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease

Table 40: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 41: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 42: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel

Table 43: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country

Table 44: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 45: Oceania Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 46: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease

Table 47: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 48: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 49: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel

Table 50: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country

Table 51: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 52: MEA Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class

Table 53: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease

Table 54: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 55: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action

Table 56: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

Figure 01: Global Antibiotic Resistance Market Volume (Mn Units) Analysis 2016-2020

Figure 02: Global Antibiotic Resistance Market Volume (Mn Units) Analysis and Forecast 2021–2031 

Figure 03: Beta Lactam Antibiotic Pricing Analysis (US$) for Per Unit, By Region, 2020

Figure 04: Cephalosporin Pricing Analysis (US$) for Per Unit, By Region, 2020

Figure 05: Quinolones Antibiotic Pricing Analysis (US$) for Per Unit, By Region, 2020

Figure 06: Macrolide Antibiotic Pricing Analysis (US$) for Per Unit, By Region, 2020

Figure 07: Tetracycline Pricing Analysis (US$) for Per Unit, By Region, 2020

Figure 08: Oxazolidinones plate Pricing Analysis (US$) for Per Unit, By Others, 2020

Figure 09: Others Pricing Analysis (US$) for Per Unit, By Region, 2020

Figure 10: Global Antibiotic Resistance Market Value (US$ Mn), 2016 – 2020

Figure 11: Global Antibiotic Resistance Market Value Analysis and Forecast 2021 – 2031 (US$ Mn)

Figure 12: Global Antibiotic Resistance Market Absolute $ Opportunity (US$ Mn), 2020–2031

Figure 13: Global Antibiotic Resistance Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 14: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Drug Class, 2021-2031

Figure 15: Global Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031

Figure 16: Global Antibiotic Resistance Market Share Analysis (%) By Pathogen 2021 & 2031

Figure 17: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Pathogen, 2021–2031

Figure 18: Global Antibiotic Resistance Market Attractiveness Analysis, By Pathogen, 2021- 2031

Figure 19: Global Antibiotic Resistance Market Share Analysis (%) By Disease, 2021 & 2031

Figure 20: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Disease, 2021- 2031

Figure 21: Global Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031

Figure 22: Global Antibiotic Resistance Market Share Analysis (%) By Mechanism of action, 2021 & 2031

Figure 23: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Mechanism of action, 2021–2031

Figure 24: Global Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031

Figure 25: Global Antibiotic Resistance Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 26: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Distribution Channel, 2021–2031

Figure 27: Global Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031

Figure 28: Global Antibiotic Resistance Market Share Analysis (%) By Region, 2021 & 2031

Figure 29: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Region, 2021–2031

Figure 30: Global Antibiotic Resistance Market Attractiveness Analysis, By Region, 2021- 2031

Figure 31: North America Antibiotic Resistance Market Value Share, By Country 2021 (E)

Figure 32: North America Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)

Figure 33: North America Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)

Figure 34: North America Antibiotic Resistance Market Value Share, By Disease 2021 (E)

Figure 35: North America Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)

Figure 36: North America Antibiotic Resistance Market Value Share, By Distribution Channel (E)

Figure 37: North America Antibiotic Resistance Market Value (US$ Mn), 2016 – 2020

Figure 38: North America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031

Figure 39: North America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031

Figure 40: North America Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031

Figure 41: North America Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031

Figure 42: North America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031

Figure 43: North America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031

Figure 44: North America Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031

Figure 45: North America Antibiotic Resistance Market Attractiveness Analysis, By Country, 2021- 2031

Figure 46: Latin America Antibiotic Resistance Market Value Share, By Country 2021 (E)

Figure 47: Latin America Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)

Figure 48: Latin America Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)

Figure 49: Latin America Antibiotic Resistance Market Value Share, By Disease 2021 (E)

Figure 50: Latin America Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)

Figure 51: Latin America Antibiotic Resistance Market Value Share, By Distribution Channel (E)

Figure 52: Latin America Antibiotic Resistance Market Value (US$ Mn), 2016 – 2020

Figure 53: Latin America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031

Figure 54: Latin America Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031

Figure 55: Latin America Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031

Figure 56: Latin America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031

Figure 57: Latin America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031

Figure 58: Latin America Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031

Figure 59: Latin America Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031

Figure 60: Europe Antibiotic Resistance Market Value Share, By Country

Figure 61: Europe Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)

Figure 62: Europe Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)

Figure 63: Europe Antibiotic Resistance Market Value Share, By Disease 2021 (E)

Figure 64: Europe Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)

Figure 65: Europe Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)

Figure 66: Europe Antibiotic Resistance Market Value (US$ Mn), 2016 – 2020

Figure 67: Europe Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031

Figure 68: Europe Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031

Figure 69: Europe Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031

Figure 70: Europe Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031

Figure 71: Europe Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031

Figure 72: Europe Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031

Figure 73: South Asia Antibiotic Resistance Market Value Share, By Country 2021 (E)

Figure 74: South Asia Antibiotic Resistance Market Value (US$ Mn), 2016 – 2020

 

Figure 75: South Asia Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)

Figure 76: South Asia Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)

Figure 77: South Asia Antibiotic Resistance Market Value Share, By Disease 2021 (E)

Figure 78: South Asia Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)

Figure 79: South Asia Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)

Figure 80: South Asia Antibiotic Resistance Market Value (US$ Mn) 2016-2020

Figure 81: South Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031

Figure 82: South Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031

Figure 83: South Asia Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031

Figure 84: South Asia Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031

Figure 85: South Asia Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031

Figure 86: South Asia Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031

Figure 87: South Asia Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031

Figure 88: East Asia Antibiotic Resistance Market Value Share, By Country 2021 (E)

Figure 89: East Asia Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)

Figure 90: East Asia Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)

Figure 91: East Asia Antibiotic Resistance Market Value Share, By Disease 2021 (E)

Figure 92: East Asia Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)

Figure 93: East Asia Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)

Figure 94: East Asia Antibiotic Resistance Market Value (US$ Mn), 2016 – 2020

Figure 95: East Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031

Figure 96: East Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031

Figure 97: East Asia Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031

Figure 98: East Asia Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031

Figure 99: East Asia Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031

Figure 100: East Asia Antibiotic Resistance Market Attractiveness Analysis By Distribution Channel, 2021- 2031

Figure 101: Oceania Antibiotic Resistance Market Value Share, By Country 2021 (E)

Figure 102: Oceania Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)

Figure 103: Oceania Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)

Figure 104: Oceania Antibiotic Resistance Market Value Share, By Disease 2021 (E)

Figure 105: Oceania Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)

Figure 106: Oceania Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)

Figure 107: Oceania Antibiotic Resistance Market Value (US$ Mn), 2016 – 2020

Figure 108: Oceania Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031

Figure 109: Oceania Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031

Figure 110: Oceania Antibiotic Resistance Market Attractiveness Analysis By Drug Class, 2021- 2031

Figure 111: Oceania Antibiotic Resistance Market Attractiveness Analysis By Disease, 2021- 2031

Figure 112: Oceania Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031

Figure 113: Oceania Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031

Figure 114: Oceania Antibiotic Resistance Market Attractiveness Analysis By Distribution Channel, 2021- 2031

Figure 115: MEA Antibiotic Resistance Market Value Share, By Country 2021 (E)

Figure 116: MEA Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)

Figure 117: MEA Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)

Figure 118: MEA Antibiotic Resistance Market Value Share, By Disease 2021 (E)

Figure 119: MEA Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)

Figure 120: MEA Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)

Figure 130: MEA Antibiotic Resistance Market Value (US$ Mn), 2016 – 2020

Figure 131: MEA Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031

Figure 132: MEA Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031

Figure 133: MEA Antibiotic Resistance Market Attractiveness Analysis By Drug Class, 2021- 2031

Figure 134: MEA Antibiotic Resistance Market Attractiveness Analysis By Disease, 2021- 2031

Figure 135: MEA Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031

Figure 136: MEA Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031

Figure 137: MEA Antibiotic Resistance Market Attractiveness Analysis By Distribution Channel, 2021- 2031

Figure 138: US. Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 139: US. Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 140: US. Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 141: US. Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 142: US. Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 143: Canada Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 144: Canada Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 145: Canada Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 146: Canada Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 147: Canada Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 148: Brazil Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 149: Brazil Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 150: Brazil Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 151: Brazil Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 152: Brazil Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 153: Mexico Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 154: Mexico Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 155: Mexico Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 156: Mexico Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 157: Mexico Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 158: Argentina Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 159: Argentina Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 160: Argentina Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 161: Argentina Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 162: Argentina Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 163: Germany Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 164: Germany Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 165: Germany Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 166: Germany Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 167: Germany Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 168: Italy Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 169: Italy Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 170: Italy Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 171: Italy Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 172: Italy Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 173: France Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 174: France Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 175: France Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 176: France Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 177: France Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 178: U.K. Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 179: U.K. Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 180: U.K. Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 181: U.K. Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 182: U.K. Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 183: Spain Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 184: Spain Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 185: Spain Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 186: Spain Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 187: Spain Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 188: BENELUX Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 189: BENELUX Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 190: BENELUX Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 191: BENELUX Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 192: BENELUX Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 193: Russia Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 194: Russia Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 195: Russia Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 196: Russia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 197: Russia Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 198: India Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 199: India Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 200: India Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 201: India Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 202: India Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 203: Thailand Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 204: Thailand Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 205: Thailand Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 206: Thailand Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 207: Thailand Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 208: Malaysia Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 209: Malaysia Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 210: Malaysia Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 211: Malaysia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 212: Malaysia Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 213: China Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 214: China Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 215: China Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)

Figure 216: China Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 217: China Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 218: Japan Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 219: Japan Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 220: Japan Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 221; Japan Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 222: Japan Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 223: Australia Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 224: Australia Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 225: Australia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 226: Australia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 227: Australia Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 228: New Zealand Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 229: New Zealand Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 230: New Zealand Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 231: New Zealand Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 232: New Zealand Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 233: GCC Countries Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 234: GCC Countries Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 235: GCC Countries Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 236: GCC Countries Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 237: GCC Countries Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 238: Turkey Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 239: Turkey Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 240: Turkey Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 241: Turkey Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 242: Turkey Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Figure 243: South Africa Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)

Figure 244: South Africa Antibiotic Resistance Market Value Share, By Disease, 2021 (E)

Figure 245: South Africa Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 246: South Africa Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)

Figure 247: South Africa Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Recommendations

Asia Pacific North America Europe Fluorinated Solvents Market

The Asia Pacific Fluorinated Solvents market is expected to register a CAGR of 9.0% over the forecast period (2018–2026)..

White Spirit Market

White Spirits Market are of four types - Type 1, Type 2, Type 3, and Type 0, which are categorized on their aromatic content basis. White spirits are consumed in a wide range of applications such as paint thinners, cleaning solvents, degreasing solvents, fuels, and disinfectants, among others..

2-Ethylhexanol Market

South Asia and Pacific and MEA, are estimated to witness a steady growth spurred by rapid economic development. These regions are estimated to hold a prominent share in the 2-ethylhexanol market during the forecast period..

Behenyl Alcohol Market

The behenyl alcohol market has seen steady demand from the cosmetics industry. Moreover, globally, per capita consumption of cosmetics is increasing at a rate of 3.4% per year.

Our Clients

Our Clients